A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia
Condition: Low/Intermediate Risk-1 MDS Interventions: Drug: Danazol + rhTPO (recombinant human thrombopoietin injection); Drug: Danazol + sodium chloride Sponsor: Peking Union Medical College Hospital Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials